Brind.

Compass Pathways established its operational footprint as of July 2025, including headquarters in London, offices in New York, and Breakthrough Therapy designation from the FDA.

3 reports, 1 independent Updated Jul 29
Gone quiet
Reports
3
Developments
2
Repetition
67%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Compass Pathways established its operational footprint as of July 2025, including headquarters in London, offices in New York, and Breakthrough Therapy designation from the FDA.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. RBC Capital Markets provides analyst commentary regarding the FDA's regulation of psychedelic drug development at Compass.Sub-event
  2. Compass Pathways is headquartered in London, with offices in New York, and holds Breakthrough Therapy designation from the FDA.1 source

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped
  • Business WireCompass Pathways to Announce Second Quarter Financial Results on July 31, 2025 Compass management will host a conference call at 8:00 am ET (1:00 pm UK) LONDON & NEW YORK, July 22, 2025--(BUSINESS WI
  • Unknown outlet
1 more outlet ran the same wire story